About Universitaetsklinikum Heidelberg Medizinische Klinik V
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Universitaetsklinikum Heidelberg Medizinische Klinik V
During the past decade, Universitaetsklinikum Heidelberg Medizinische Klinik V conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on
average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universitaetsklinikum Heidelberg Medizinische Klinik V" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "University of Heidelberg Medical Center" with 3 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "University Hospital Muenster" with 2 trials sponsored and "Carsten Müller-Tidow"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitaetsklinikum Heidelberg Medizinische Klinik V"
#1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Array BioPharma" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Coordinating Centre for Clinical Trials Heidelberg" with 1 trials as a collaborator and "German Cancer Research Center" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Universitaetsklinikum Heidelberg Medizinische Klinik V
According to Clinical.Site data, the most researched conditions in "Universitaetsklinikum Heidelberg Medizinische Klinik V" are
"Multiple Myeloma" (4 trials), "Rheumatoid Arthritis" (3 trials), "Amyloidosis" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "CD20+ Aggressive B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Universitaetsklinikum Heidelberg Medizinische Klinik V" in a lesser frequency.
Clinical Trials Intervention Types at Universitaetsklinikum Heidelberg Medizinische Klinik V
Most popular intervention types in "Universitaetsklinikum Heidelberg Medizinische Klinik V" are "Drug" (18 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (7 trials), "Bortezomib" (4 trials), "Cyclophosphamide" (4 trials), "Cytarabine" (3 trials) and "Methotrexate" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Universitaetsklinikum Heidelberg Medizinische Klinik V
The vast majority of trials in "Universitaetsklinikum Heidelberg Medizinische Klinik V" are
19 trials for "All" genders.
Clinical Trials Status at Universitaetsklinikum Heidelberg Medizinische Klinik V
Currently, there are NaN active trials in "Universitaetsklinikum Heidelberg Medizinische Klinik V".
undefined are not yet recruiting,
5 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Universitaetsklinikum Heidelberg Medizinische Klinik V,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Universitaetsklinikum Heidelberg Medizinische Klinik V, 2 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".